Carla I. Falkson

Phase III Randomized Trial Comparing Doxorubicin and Cyclophosphamide Followed by Docetaxel (AC→T) with Doxorubicin and Cyclophosphamide Followed by Docetaxel and Trastuzumab (AC→TH) with Docetaxel, Carboplatin and Trastuzumab (TCH) in Her2neu Positive Early Breast Cancer Patients: BCIRG 006 Study.

DJ Slamon, W. Eiermann, Nicholas J. Robert et al. · Cancer Research · 2009 · 554 citations

Medicine, Oncology, Pharmacology +17

Tumor Exosomes Inhibit Differentiation of Bone Marrow Dendritic Cells

Shaohua Yu, Cunren Liu, Kaihong Su et al. · The Journal of Immunology · 2007 · 426 citations

Life Sciences, Immunology, Oncology +17

Docetaxel and Doxorubicin Compared With Doxorubicin and Cyclophosphamide as First-Line Chemotherapy for Metastatic Breast Cancer: Results of a Randomized, Multicenter, Phase III Trial

Jean‐Marc Nabholtz, Carla I. Falkson, J. Szántó et al. · Journal of Clinical Oncology · 2003 · 384 citations

Medicine, Oncology, Pharmacology +12

Phase III trial of dacarbazine versus dacarbazine with interferon alpha-2b versus dacarbazine with tamoxifen versus dacarbazine with interferon alpha-2b and tamoxifen in patients with metastatic malignant melanoma: an Eastern Cooperative Oncology Group study.

Carla I. Falkson, Joseph Ibrahim, John M. Kirkwood et al. · Journal of Clinical Oncology · 1998 · 304 citations

Pharmacy, Oncology, Pharmacotherapy +14

Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy With Disease Recurrence in Patients With Triple-Negative Breast Cancer

Milan Radovich, Guanglong Jiang, Bradley A. Hancock et al. · JAMA Oncology · 2020 · 302 citations · Full text

Medicine, Oncology, Breast Oncology +16